default author photo

Vincent van der Noort

Netherlands Cancer Institute - Department of Biometrics

SCHOLARLY PAPERS

2

DOWNLOADS

96

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Upfront Resection of Locally-Advanced And/Or Cavitating Nsclc Followed by Chemoradiotherapy (and Adjuvant Systemic Treatment); Phase 1 Multicenter Study to Assess Treatment Feasibility and Safety (NVALT32/UPLAN-I Trial)

Number of pages: 28 Posted: 21 Mar 2023
P.J.M. Joosten, R.G. Luger, Vincent van der Noort, W.S.M.E. Theelen, M.C. de Jong, K. Monkhorst, Ad F.T.M. Verhagen, Michel van den Heuvel, A.C. Dingemans, A.P.W.M. Maat, L.E.L. Hendriks, Merlijn Hutteman, Anthonie J. van der Wekken, A.M. Slats, Egbert Smit and K.J. Hartemink
Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Netherlands Cancer Institute Antoni van Leeuwenhoek, Radboud University Nijmegen - Radboud University Medical Center, Radboud University Nijmegen - Department of Pulmonary Diseases, Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Erasmus University Rotterdam (EUR) - Erasmus Medical Center (MC), Maastricht University Medical Center, Leiden University - Leiden University Medical Center (LUMC), University of Groningen - University Medical Center Groningen, Leiden University - Leiden University Medical Center (LUMC), Netherlands Cancer Institute Antoni van Leeuwenhoek and Netherlands Cancer Institute Antoni van Leeuwenhoek
Downloads 63 (933,592)

Abstract:

Loading...

Locally-advanced NSCLCChemoradiotherapyLarge tumor volumeCavitationUpfront surgeryFeasibilitySafety

2.

Enhancer Profiling Identifies Epigenetic Markers of Endocrine Resistance and Reveals Therapeutic Options for Metastatic Castration-Resistant Prostate Cancer Patients

Number of pages: 88 Posted: 13 Mar 2023
Tesa M. Severson, Yanyun Zhu, Stefan Prekovic, Karianne Schuurman, Holly M. Nguyen, Lisha G. Brown, Sini Hakkola, Yongsoo Kim, Jeroen Kneppers, Simon Linder, Suzan Stelloo, Cor Lieftink, Michiel S. van der Heijden, Matti Nykter, Vincent van der Noort, Joyce Sanders, Ben Morris, Guido Jenster, Geert JLH van Leenders, Mark Pomerantz, Matthew L. Freedman, Roderick Beijersbergen, Alfonso Urbanucci, Lodewyk Wessels, Eva Corey, Wilbert Zwart and Andries M. Bergman
Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, University of Washington - Department of Urology, University of Washington - Department of Urology, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, VU University Amsterdam - Department of Pathology, Cancer Center Amsterdam, Amsterdam UMC, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Oncogenomics, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Department of Biometrics, Netherlands Cancer Institute - Department of Pathology, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Erasmus University Rotterdam (EUR) - Department of Urology, Erasmus University Rotterdam (EUR) - Department of Pathology, Cancer Institute, Harvard University - Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard University - Dana-Farber Cancer Institute, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, Tampere University - Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tays Cancer Centre, Netherlands Cancer Institute - Division of Molecular Carcinogenesis, University of Washington - Department of Urology, Netherlands Cancer Institute - Division of Oncogenomics and Netherlands Cancer Institute - Division of Oncogenomics
Downloads 33 (1,277,121)

Abstract:

Loading...

mCRPC, enzalutamide, epigenetics, androgen receptor, H3K27ac, HDAC inhibitors, biomarkers, hormone intervention